Literature DB >> 21901248

Fibulin-3 promoter methylation alters the invasive behavior of non-small cell lung cancer cell lines via MMP-7 and MMP-2 regulation.

Eun Jin Kim1, So Yong Lee, Mi Kyung Woo, Soo Im Choi, Tae Rim Kim, Min-Jung Kim, Kug Chan Kim, Eun Wie Cho, In Gyu Kim.   

Abstract

Fibulin-3, an extracellular glycoprotein, has been suggested as having functions in tissue regeneration and organogenesis. However, its role in cancer remains unclear. We show here that fibulin-3 was silenced by hypermethylation of the promoter region in the relatively invasive A549 non-small cell lung cancer (NSCLC) cells compared with less invasive H460 NSCLC cells. Enforced expression of fibulin-3 in A549 cells down-regulated cellular MMP-7 and MMP-2, which was followed by inhibition of cell invasiveness. Conversely, suppression of fibulin-3 expression with siRNA in H460 cells showed the opposite effect. These results indicate that fibulin-3 is a negative regulator of invasiveness in NSCLC and further studies are needed for its therapeutic applications in treatment of NSCLC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21901248     DOI: 10.3892/ijo.2011.1191

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  31 in total

1.  Fibulin-3 promotes muscle-invasive bladder cancer.

Authors:  A L Han; B A Veeneman; L El-Sawy; K C Day; M L Day; S A Tomlins; E T Keller
Journal:  Oncogene       Date:  2017-05-15       Impact factor: 9.867

2.  A high-throughput cell-based Gaussia luciferase reporter assay for identifying modulators of fibulin-3 secretion.

Authors:  John D Hulleman; Steven J Brown; Hugh Rosen; Jeffery W Kelly
Journal:  J Biomol Screen       Date:  2012-12-10

3.  Prognostic value of matrix metalloproteinase-7 expression in patients with non-small cell lung cancer.

Authors:  Yonggang Liang; Shanxian Guo; Qinghua Zhou
Journal:  Tumour Biol       Date:  2013-12-14

4.  Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma.

Authors:  Harvey I Pass; Stephen M Levin; Michael R Harbut; Jonathan Melamed; Luis Chiriboga; Jessica Donington; Margaret Huflejt; Michele Carbone; David Chia; Lee Goodglick; Gary E Goodman; Mark D Thornquist; Geoffrey Liu; Marc de Perrot; Ming-Sound Tsao; Chandra Goparaju
Journal:  N Engl J Med       Date:  2012-10-11       Impact factor: 91.245

5.  p38 MAPK down-regulates fibulin 3 expression through methylation of gene regulatory sequences: role in migration and invasion.

Authors:  María Arechederra; Neibla Priego; Ana Vázquez-Carballo; Celia Sequera; Álvaro Gutiérrez-Uzquiza; María Isabel Cerezo-Guisado; Sara Ortiz-Rivero; Cesáreo Roncero; Ana Cuenda; Carmen Guerrero; Almudena Porras
Journal:  J Biol Chem       Date:  2014-12-29       Impact factor: 5.157

Review 6.  Epigenomic and enhancer dysregulation in uterine leiomyomas.

Authors:  Oliwia W Mlodawska; Priyanka Saini; J Brandon Parker; Jian-Jun Wei; Serdar E Bulun; Melissa A Simon; Debabrata Chakravarti
Journal:  Hum Reprod Update       Date:  2022-06-30       Impact factor: 17.179

7.  Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 expression and regulation in uterine leiomyoma.

Authors:  Erica E Marsh; Shani Chibber; Ju Wu; Kendra Siegersma; Julie Kim; Serdar Bulun
Journal:  Fertil Steril       Date:  2015-12-17       Impact factor: 7.329

8.  Fibulin-4 is associated with tumor progression and a poor prognosis in ovarian carcinomas.

Authors:  Jie Chen; Zhao Liu; Shuang Fang; Rui Fang; Xi Liu; Yueran Zhao; XiangXin Li; Lei Huang; Jie Zhang
Journal:  BMC Cancer       Date:  2015-03-04       Impact factor: 4.430

9.  Elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma.

Authors:  Ji-Chang Han; Xian-Dong Li; Jin Du; Feng Xu; Yu-Ju Wei; Hong-Bing Li; Yi-Jie Zhang
Journal:  World J Surg Oncol       Date:  2015-01-14       Impact factor: 2.754

10.  Kaiso directs the transcriptional corepressor MTG16 to the Kaiso binding site in target promoters.

Authors:  Caitlyn W Barrett; J Joshua Smith; Lauren C Lu; Nicholas Markham; Kristy R Stengel; Sarah P Short; Baolin Zhang; Aubrey A Hunt; Barbara M Fingleton; Robert H Carnahan; Michael E Engel; Xi Chen; R Daniel Beauchamp; Keith T Wilson; Scott W Hiebert; Albert B Reynolds; Christopher S Williams
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.